HEPATITIS-B DEFECTIVE VIRUS WITH REARRANGEMENTS IN THE PRES-GENE DURING CHRONIC HBV INFECTION

被引:138
作者
GERKEN, G
KREMSDORF, D
CAPEL, F
PETIT, MA
DAUGUET, C
MANNS, MP
ZUMBUSCHENFELDE, KHM
BRECHOT, C
机构
[1] UNIV MAINZ, INST MED KLIN & POLIKLIN, W-6500 MAINZ, GERMANY
[2] INSERM, U131, F-75005 PARIS, FRANCE
[3] INST PASTEUR, UNITE ONCOL, F-75724 PARIS 15, FRANCE
[4] INST PASTEUR, HYBRIDOTEST LAB, F-75724 PARIS 15, FRANCE
关键词
D O I
10.1016/0042-6822(91)90984-J
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We have found a defective form of HBV in a HBsAg- and anti-HBe-positive patient with liver cancer. Viral deletions were identified in the preS coding region using PCR. The presence of deleted HBV forms was observed in serum, PBMC, and liver samples. After sequencing 12 clones were analyzed (subtype adr). In 9 out of 12 clones a 183-bp in-frame deletion was recorded in the preS1 region (2995 to 3177). Three out of 9 clones also yielded rearrangements of the preS2 N-terminal part. Four out of 9 showed numerous point mutations in the preS1 and preS2 sequence. In addition, 3 out of 12 clones, which did not show the 183-bp preS1 deletion were found to have small deletions and insertions in the same part of the preS1 gene. Immunological mapping using monoclonal anti-preS antibodies showed loss of preS epitopes located at the 3′-part of preS1 and the 5′-part of preS2. On the other hand, epitopes mapped to the 5′-part of preS1 and 3′ of preS2 were conserved. PBMC were also tested and solely PCR showed the major form of defective HBV with preS1 183-bp deletion. However, viral deletions in the preS gene eliminated the preS2 promotor region and B- and T-cell recognition sites. In contrast to this, the preS1 binding site to hepatocytes was conserved. Therefore, such deletions would potentially lead to an impairment in viral clearance without affecting viral penetration in liver cells, possibly accounting for chronic HBV infection. © 1991.
引用
收藏
页码:555 / 565
页数:11
相关论文
共 60 条
[1]   ORGAN-SPECIFIC SELECTION OF VIRAL VARIANTS DURING CHRONIC INFECTION [J].
AHMED, R ;
OLDSTONE, MBA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 167 (05) :1719-1724
[2]  
ALBERTI A, 1990, SPRINGER SEMIN IMMUN, V12, P5
[3]   HEPATITIS-B VIRUS (HBV) PROMOTERS ARE REGULATED BY THE HBV ENHANCER IN A TISSUE-SPECIFIC MANNER [J].
ANTONUCCI, TK ;
RUTTER, WJ .
JOURNAL OF VIROLOGY, 1989, 63 (02) :579-583
[4]   THE AMINO-TERMINAL DOMAIN OF THE HEPADNAVIRAL P-GENE ENCODES THE TERMINAL PROTEIN (GENOME-LINKED PROTEIN) BELIEVED TO PRIME REVERSE TRANSCRIPTION [J].
BARTENSCHLAGER, R ;
SCHALLER, H .
EMBO JOURNAL, 1988, 7 (13) :4185-4192
[5]   A NEW HEPATITIS-B VIRUS-STRAIN IN PATIENTS WITH SEVERE ANTI-HBE POSITIVE CHRONIC HEPATITIS-B [J].
BRUNETTO, MR ;
STEMLER, M ;
BONINO, F ;
SCHODEL, F ;
OLIVERI, F ;
RIZZETTO, M ;
VERME, G ;
WILL, H .
JOURNAL OF HEPATOLOGY, 1990, 10 (02) :258-261
[6]   HEPATITIS-B VIRUS PRE-S GENE-ENCODED ANTIGENIC SPECIFICITY AND ANTI-PRE-S ANTIBODY - RELATIONSHIP BETWEEN ANTI-PRE-S RESPONSE AND RECOVERY [J].
BUDKOWSKA, A ;
DUBREUIL, P ;
CAPEL, F ;
PILLOT, J .
HEPATOLOGY, 1986, 6 (03) :360-368
[7]  
CARMAN WF, 1989, LANCET, V2, P588
[8]   MOLECULAR PATHOGENESIS OF HEPATOCELLULAR-CARCINOMA IN HEPATITIS-B VIRUS TRANSGENIC MICE [J].
CHISARI, FV ;
KLOPCHIN, K ;
MORIYAMA, T ;
PASQUINELLI, C ;
DUNSFORD, HA ;
SELL, S ;
PINKERT, CA ;
BRINSTER, RL ;
PALMITER, RD .
CELL, 1989, 59 (06) :1145-1156
[9]   ANTI-PRE-S2 ANTIBODIES IN NATURAL HEPATITIS-B VIRUS-INFECTION AND AFTER IMMUNIZATION [J].
COURSAGET, P ;
ADAMOWICZ, P ;
BOURDIL, C ;
YVONNET, B ;
BUISSON, Y ;
BARRES, JL ;
SALIOU, P ;
CHIRON, JP ;
MAR, ID .
VACCINE, 1988, 6 (04) :357-361
[10]  
DEEPEN R, 1990, MED MICROBIOL IMMUN, V179, P49